Medicine, Endocrinology Division

Grants

Grants per year 1999 2004 2009 2012 2016 2027

• 58 Active
• 353 Finished

Grants per year

Search results

• Finished

  Measuring Human BAT Volume and Activity by Quantitative and Functional MRI

  Neff, L. M.

  Ann & Robert H. Lurie Children's Hospital of Chicago, National Institute of Diabetes and Digestive and Kidney Diseases

  7/1/14 → 12/31/16

  Project: Research project

  • bats 100%
  • volume 50%
  • positron computed tomography 50%
  • Positron Emission Tomography-Computed Tomography 50%
  • Development 50%

• LCI699C2301, entitled " A Phase III, Multi-Center Double-Blind, Randomized, Withdrawal Study of LCI699 Following a 24 Week, Single-Arm, Open-Label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patie

  Huang, W. & Molitch, M. E.

  Novartis Pharmaceuticals Corporation

  6/20/14 → 6/30/20

  Project: Research project

• Molecular Clock Regulation of b-cell Gene Networks in T1DM

  Bass, J. & Barish, G. D.

  JDRF International

  6/1/14 → 5/31/16

  Project: Research project

  • Gene 100%
  • Molecular Clock 90%
  • Cell Function 90%
  • Epigenetic Modification 80%
  • Circadian Rhythm 80%

• Chicago Area Patient Centered Outcomes Research Network, CAPriCORN

  Kho, A. N., Rothrock, N. E., Avila, P. C., Bass, M., Cella, D. & Kushner, R. F.

  Chicago Community Trust, Patient-Centered Outcomes Research Institute

  3/1/14 → 8/31/15

  Project: Research project

  • Outcomes Research 100%
  • Patient 71%
  • Medical Centres 50%
  • patients 50%
  • Patients 42%

• Prot # CSOM230CUS33: An Acromegaly, Open-label, Multi-Center, Safety Monitoring Program for Treating Patients with SOM230 (Pasireotide) LAR Who Have Need to Receive Medical Therapy (ACCESS)

  Molitch, M. E.

  Novartis Pharmaceuticals Corporation

  2/21/14 → 12/31/15

  Project: Research project

• Grant #6199, Northwestern Medicine Healthy Patient Initiative

  Kushner, R. F.

  Anonymous Foundation (VI)

  2/13/14 → 12/31/18

  Project: Research project

  • Health Behavior 100%
  • Patient 75%
  • Self Help 50%
  • Medical Centres 50%
  • Counseling 50%

• Prot #BAY 94-8862/16243: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY-94-8862 in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropa

  Molitch, M. E., Batlle, D. & Wallia, A.

  Bayer HealthCare Pharmaceuticals, Inc.

  1/2/14 → 1/2/17

  Project: Research project

• A Novel Type 2 Diabetes Treatment Biased Agonists for Free Fatty Acid Receptor 2

  Layden, B. T.

  Northwestern Memorial Hospital

  1/1/14 → 12/31/15

  Project: Research project

  • Maturity Onset Diabetes of the Young 100%
  • Insulin Release 100%
  • Glucose 80%
  • Nested Gene 80%
  • Receptor 59%

• Trial of PERL: A Multicenter Clinical Allopurinol to prevent GFR loss in T1D

  Molitch, M. E.

  Joslin Diabetes Center, Inc., JDRF International

  12/1/13 → 6/30/16

  Project: Research project

  • Trial 100%
  • clinical trials 75%
  • losses 50%
  • Prevents 50%
  • Patient 25%

• A Novel Hexokinase, HKDC1, regulates glucose homeostasis during pregnancy

  Layden, B. T.

  American Diabetes Association

  11/1/13 → 10/31/14

  Project: Research project

  • hexokinase 100%
  • Hexokinase 100%
  • genes 41%
  • data 41%
  • Nested Gene 41%

• PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D

  Molitch, M. E., Batlle, D. & Wallia, A.

  Joslin Diabetes Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases

  9/30/13 → 8/31/17

  Project: Research project

  • Allopurinol 100%
  • Serum 75%
  • Uric Acid 25%
  • Analysis of Covariance 25%
  • Ramipril 25%

• Hearing Impairment in Long-Term Type 1 Diabetes

  Molitch, M. E.

  Case Western Reserve University, National Institute of Diabetes and Digestive and Kidney Diseases

  9/30/13 → 8/31/17

  Project: Research project

  • Audiometry 100%
  • Questionnaire 90%
  • Data Collection 90%
  • Control Subject 90%
  • Hearing Impairment 66%

• Promoting the Universal Medication Schedule via Mobile and EHR Technologies

  Wolf, M., Wallia, A. & Kim, K. A.

  Merck Sharp & Dohme Corporation

  9/4/13 → 2/28/17

  Project: Research project

• Genetics and Genomics of Maternal Glycemia During Pregnancy

  Lowe Jr, W. L., Hayes, M. G., Lowe, L. P. & Metzger, B. E.

  National Institute of Diabetes and Digestive and Kidney Diseases

  9/1/13 → 6/30/16

  Project: Research project

• Molecular Clock in the Initiation and Progression of Islet Autoimmunity

  Bass, J. & Miller, S. D.

  JDRF International and The Leona M. and Harry B. Helmsley Charitable Trust

  9/1/13 → 8/31/16

  Project: Research project

  • Beta Cell 100%
  • Autoimmunity 60%
  • Immunogenicity 40%
  • Diabetes Mellitus Type 1 40%
  • Circadian Rhythm 30%

• Discovering the Role of Metabolomics in the Pathogenesis of Leiomyomas: A Pilot Study Utilizing the NIEHS SELF (Study of the Environment, Lifestyle and Fibroids) Cohort

  Marsh, E. E., Carnethon, M. R. & Neff, L. M.

  Northwestern Memorial Hospital

  9/1/13 → 8/31/14

  Project: Research project

• Prot # CP-4-005: A Phase 3, Multicenter Study Designed to Evaluate the Efficacy and Safety of a Long Acting hGH Product (MOD-4023) in Adult Subjects with Growth Hormone Deficiency

  Molitch, M. E. & Wallia, A.

  inVentiv Health Clinical, Prolor Biotech Ltd.

  8/22/13 → 8/21/18

  Project: Research project

• Preclinical Investigation of a Bioengineered Vascular Graft

  Ameer, G. A., Carroll, T. J., Bass, J., Carroll, T. J. & Meade, T. J.

  National Institute of Biomedical Imaging and Bioengineering

  8/15/13 → 7/31/16

  Project: Research project

  • Arteriosclerosis Obliterans 100%
  • Politef 84%
  • Endothelial Progenitor Cell 75%
  • grafts 69%
  • Vascular Bundle 67%

• Genetics and Evolution of Fetal Human Fat Accretion During Development

  Lowe Jr, W. L., Hayes, M. G., Lowe, L. P. & Metzger, B. E.

  National Institute of Diabetes and Digestive and Kidney Diseases

  7/1/13 → 5/31/16

  Project: Research project

• Prot #09-1: A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Comparing the EndoBarrier® Gastrointestinal Liner System vs. Sham for Glycemic Improvement in Inadequately Controlled Obese Type 2 Diabetic Subjects on Metformin and/or Sulfonylurea

  Neff, L. M.

  GI Dynamics, Inc.

  6/24/13 → 1/31/17

  Project: Research project

• Vitamin D and type 2 diabetes (D2d study)

  Neff, L. M., Hahr, A. J. & Molitch, M. E.

  Tufts University, National Institute of Diabetes and Digestive and Kidney Diseases

  6/1/13 → 5/31/16

  Project: Research project

  • Impaired Glucose Tolerance 100%
  • Colecalciferol 50%
  • Maturity Onset Diabetes of the Young 50%
  • Clinical Diabetes 50%
  • Supplementation 50%

• Developing a Longitudinal Resource for Genetic Research in Behavioral and Health Sciences

  Hayes, M. G. & Freese, J.

  University of Wisconsin-Madison, National Institute on Aging

  6/1/13 → 4/30/15

  Project: Research project

• Vitamin D and type 2 diabetes (D2d study) [Cost Reimbursable Sub Project for Personnel Costs]

  Neff, L. M.

  Tufts University, National Institute of Diabetes and Digestive and Kidney Diseases

  6/1/13 → 5/31/16

  Project: Research project

  • Impaired Glucose Tolerance 100%
  • Colecalciferol 50%
  • Maturity Onset Diabetes of the Young 50%
  • Clinical Diabetes 50%
  • Supplementation 50%

• Fixed Price Subproject for Vitamin D and type 2 diabetes (D2d study)

  Neff, L. M.

  Tufts University, National Institute of Diabetes and Digestive and Kidney Diseases

  6/1/13 → 5/31/16

  Project: Research project

  • Impaired Glucose Tolerance 100%
  • Diabetes 66%
  • Colecalciferol 50%
  • Maturity Onset Diabetes of the Young 50%
  • Clinical Diabetes 50%

• Maternal Obesity and Gestational Diabetes: Impact on Metabolome

  Lowe Jr, W. L., Lowe, L. P., Metzger, B. E., Scholtens, D. M. & Fought, A. J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  4/1/13 → 2/29/16

  Project: Research project